The first large-scale genetic study of Escherichia coli (E ... that a different strategy may be needed to help reduce E. coli blood infections. Tim Jinks, Head of Drug-Resistant Infections ...

A vaccine targeting that protein could potentially protect people with type A blood against the deadliest effects of enterotoxigenic E. coli (Escherichia coli) infection. "We think this protein is ...

coli, short for Escherichia coli, is a type of bacteria ... Interestingly, your blood type might also play a role in how sick ...

The data support the continued development of SYNB1020 which is currently being evaluated in a Phase 1b/2a clinical trial in patients with cirrhosis and elevated blood ammonia. "These data ...

One out of ten E. coli samples contained variants that are resistant to several kinds of antibiotics, a new analysis on Norwegian blood samples revealed. The proportion of multi-resistant E.